OLMA
OLMA
NASDAQ · Biotechnology

Olema Pharmaceuticals Inc

$9.82
-0.08 (-0.81%)
As of Sep 20, 10:07 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +71.2% upside
Low Target $15.48
Average Target $16.81
High Target $21.94
Current Price $9.82
Current
$9.82
Target
$16.81
$15.48 $16.81 avg $21.94
Scenario Analysis
Bear Case
$15.48
57.6%
Low target
Base Case
$16.81
+71.2%
Avg target
Bull Case
$21.94
+123.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$36.26
-72.9% from high
52-Week Low
$6.65
+47.7% from low
Target vs 52W High
$16.81
-53.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%